Amarantus Bioscience Holdings Inc (EM) (AMBS)

Sec Staff Action/letter (sec Staff)

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under the Securities Exchange...

Amended Statement of Beneficial Ownership (sc 13d/a)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under the Securities...

Statement of Beneficial Ownership (sc 13d)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D  ...

Statement of Beneficial Ownership (sc 13d)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under...

Statement of Beneficial Ownership (sc 13d)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D  ...

Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA

Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000...

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori    Strong customer retention at both stores in Dallas, TX...

Withdrawal of Offering Statement Under Regulation a (1-a-w)

  AMARANTUS BIOSCIENCE HOLDINGS, INC.       January 9...

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 1-A REGULATION A OFFERING...

Registration a Offering Under the Securities Act of 1933 (1-a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 1-A REGULATION A OFFERING...

Amarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson's Disease

Amarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease Patent...

Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products

Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products  Amarantus is...

Registration a Offering Under the Securities Act of 1933 (1-a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 1-A REGULATION A OFFERING...

Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp Industry

Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp Industry   New York...